This protocol covers children younger than 16 years of age with juvenile myoclonic epilepsy who are experiencing myoclonic seizures.
When single-agent therapy has been fully explored, the evidence-based approach for this population advances to combination (adjunctive) antiepileptic drug therapy — using two or more indicated agents together. The specific agents, their selection, and all related guidance are detailed in the full protocol.
Children (younger than 16 years). Myoclonic.
Monotherapy with all indicated AEDs should be attempted before initiating combination therapy.
View source ↗